Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CADENCE DESIGN SYSTEMS INCCDNS · Entity 2935 | Director | May 07, 2026 | May 11, 2026 |
| NXP Semiconductors N.V.NXPI · Entity 3013 | Director | June 10, 2026 | June 12, 2026 |
| TAIWAN SEMICONDUCTOR MANUFACTURING CO LTDTSM · Entity 2694 | Director | March 18, 2026 | March 18, 2026 |
| XILINX INCXLNX · Entity 130374 | Director · CEO | January 17, 2018 | January 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CADENCE DESIGN SYSTEMS INC
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,819 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 714 · Balance 1,819 F1: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date.
NXP Semiconductors N.V.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,808 |
Ending reported balance
After 2026-06-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-10 · Exercise / conversion · Acquired 1,035 · Balance 2,234 Row 2 · 2026-06-10 · Tax withholding · Disposed 426 · Balance 1,808 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-10 · Exercise / conversion · Disposed 1,035 · Balance 0 F1: Each Restricted Stock Unit represents the conditional right to receive one share of common stock. F2: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 06/11/2025 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 841 |
Reported balance
After 2026-06-10 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-10 · Grant · Acquired 841 · Balance 841 F3: Each Restricted Stock Unit represents the conditional right to receive one share of the common stock. F4: The Restricted Stock Unit vests 100% on the earlier of the first anniversary of the 06/10/2026 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the conditional right to receive one share of common stock.
F2: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 06/11/2025 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V.
F3: Each Restricted Stock Unit represents the conditional right to receive one share of the common stock.
F4: The Restricted Stock Unit vests 100% on the earlier of the first anniversary of the 06/10/2026 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V.
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD
Report date March 18, 2026 · Filed March 18, 2026
This filing explicitly reported no securities owned.
XILINX INC
Report date January 17, 2018 · Filed January 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| XLNX COMMON STOCKSEC Table I · non-derivative | Direct | 62,813 |
Reported balance
After 2018-01-17 transaction · row 1
1 source rowRow 1 · 2018-01-17 · Sale · Disposed 20,000 · Balance 62,813 F1: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2: Price represents weighted average for sales reported. The range of prices for the sales reported is $75.73 - $76.10 F3: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan.
F2: Price represents weighted average for sales reported. The range of prices for the sales reported is $75.73 - $76.10
F3: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 06:10 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | GrantRestricted Stock Unit · Derivative | 841 | $0.00 | $0.00 |
DisclosureSEC source: 0001165737-26-000002 · wk-form4_1781259022.xml · derivative · entry 4 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 841 Underlying: Common Stock · 841 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents the conditional right to receive one share of the common stock. F4 · derivative.exercise_date: The Restricted Stock Unit vests 100% on the earlier of the first anniversary of the 06/10/2026 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V. F4 · derivative.expiration_date: The Restricted Stock Unit vests 100% on the earlier of the first anniversary of the 06/10/2026 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 06:10 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Exercise / conversionRestricted Stock Unit · Derivative | 1,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001165737-26-000002 · wk-form4_1781259022.xml · derivative · entry 3 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,035 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the conditional right to receive one share of common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 06/11/2025 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V. F2 · derivative.expiration_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 06/11/2025 grant date and the date of the next annual general meeting of the shareholders of NXP Semiconductors N.V. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 06:10 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Tax withholdingCommon Stock | 426 | $297.41 | $126,696.66 |
DisclosureSEC source: 0001165737-26-000002 · wk-form4_1781259022.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,808 Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 06:10 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Exercise / conversionCommon Stock | 1,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001165737-26-000002 · wk-form4_1781259022.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2026 Filed May 11, 2026 21:21 UTC | CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935 | GrantCommon Stock | 714 | $0.00 | $0.00 |
DisclosureSEC source: 0000813672-26-000061 · wk-form4_1778534517.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,819 F1 · shares: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date. Read SEC document |
| January 21, 2026 Filed Mar 4, 2026 22:42 UTC | CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935 | SaleCommon Stock | 5 | $312.56 | $1,562.80 |
DisclosureSEC source: 0000813672-26-000024 · wk-form4_1772664147.xml · nonDerivative · entry 3 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,105 Read SEC document |
| December 02, 2025 Filed Mar 4, 2026 22:42 UTC | CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935 | SaleCommon Stock | 20 | $316.76 | $6,335.20 |
DisclosureSEC source: 0000813672-26-000024 · wk-form4_1772664147.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,110 Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 20:33 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | GrantRestricted Stock Unit · Derivative | 1,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001413447-25-000093 · wk-form4_1749760406.xml · derivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,035 Underlying: Common Stock · 1,035 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the conditional right to receive one share of common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 6/11/2025 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. F2 · derivative.expiration_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 6/11/2025 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:29 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Exercise / conversionRestricted Stock Unit · Derivative | 822 | $0.00 | $0.00 |
DisclosureSEC source: 0001413447-25-000061 · wk-form4_1748896142.xml · derivative · entry 3 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 822 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the conditional right to receive one share of common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 5/29/2024 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. F2 · derivative.expiration_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 5/29/2024 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:29 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Tax withholdingCommon Stock | 303 | $196.21 | $59,451.63 |
DisclosureSEC source: 0001413447-25-000061 · wk-form4_1748896142.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,199 Read SEC document |
| May 29, 2025 Filed Jun 2, 2025 20:29 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Exercise / conversionCommon Stock | 822 | $0.00 | $0.00 |
DisclosureSEC source: 0001413447-25-000061 · wk-form4_1748896142.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2025 Filed May 12, 2025 23:14 UTC | CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935 | GrantCommon Stock | 779 | $0.00 | $0.00 |
DisclosureSEC source: 0000813672-25-000062 · wk-form4_1747091681.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,046 F1 · shares: Restricted stock award fully vests on the earlier to occur of (i) the first anniversary of the Grant Date and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date. Read SEC document |
| March 28, 2025 Filed Mar 4, 2026 22:42 UTC | CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935 | PurchaseCommon Stock | 54 | $256.95 | $13,875.30 |
DisclosureSEC source: 0000813672-26-000024 · wk-form4_1772664147.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,130 F1 · balance_after: The amount reported herein reflects ownership as of the date of this filing and includes securities acquired in stock grants previously reported on Forms 4 before the filing of this Form 4. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 22:39 UTC | CADENCE DESIGN SYSTEMS INC CDNS · Entity 2935 | GrantCommon Stock | 267 | $0.00 | $0.00 |
DisclosureSEC source: 0000813672-25-000003 · wk-form4_1735943983.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267 F1 · shares: Restricted stock award fully vests on the earlier to occur of (i) May 2, 2025 and (ii) the date of the next Annual Meeting of Stockholders that follows the Grant Date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:27 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | GrantRestricted Stock Unit · Derivative | 822 | $0.00 | $0.00 |
DisclosureSEC source: 0001413447-24-000057 · wk-form4_1717190840.xml · derivative · entry 4 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 822 Underlying: Common Stock · 822 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the conditional right to receive one share of common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 5/29/2024 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. after the grant date. F3 · derivative.expiration_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 5/29/2024 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. after the grant date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:27 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Exercise / conversionRestricted Stock Unit · Derivative | 1,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001413447-24-000057 · wk-form4_1717190840.xml · derivative · entry 3 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the conditional right to receive one share of common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 11/7/2023 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. after the grant date. F2 · derivative.expiration_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 11/7/2023 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. after the grant date. Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:27 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Tax withholdingCommon Stock | 531 | $279.63 | $148,483.53 |
DisclosureSEC source: 0001413447-24-000057 · wk-form4_1717190840.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 680 Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:27 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | Exercise / conversionCommon Stock | 1,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001413447-24-000057 · wk-form4_1717190840.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2023 Filed Nov 8, 2023 21:25 UTC | NXP Semiconductors N.V. NXPI · Entity 3013 | GrantRestricted Stock Unit · Derivative | 1,211 | $0.00 | $0.00 |
DisclosureSEC source: 0001413447-23-000126 · wk-form4_1699478740.xml · derivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,211 Underlying: Common Stock · 1,211 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the conditional right to receive one share of common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 11/7/2023 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. F2 · derivative.expiration_date: The Restricted Stock Units vest 100% on the earlier of the first anniversary of the 11/7/2023 grant date and the date of the next annual general meeting of shareholders of NXP Semiconductors N.V. Read SEC document |
| January 17, 2018 Filed Jan 18, 2018 18:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 20,000 | $75.81 | $1,516,252.00 |
DisclosureSEC source: 0001246360-18-000204 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,813 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $75.73 - $76.10 F3 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 31, 2017 Filed Oct 31, 2017 17:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 28,600 | $73.66 | $2,106,533.00 |
DisclosureSEC source: 0001246360-17-002991 · form.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,813 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F4 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $73.3700 to $73.8900. F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 30, 2017 Filed Oct 31, 2017 17:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 1,400 | $73.38 | $102,736.06 |
DisclosureSEC source: 0001246360-17-002991 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,413 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $73.3700 to $73.4500. Read SEC document |
| October 06, 2017 Filed Oct 6, 2017 19:28 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 22,201 | $71.80 | $1,593,947.44 |
DisclosureSEC source: 0001246360-17-002910 · form.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,813 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F4 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $71.73 - $ 72.03 F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 05, 2017 Filed Oct 6, 2017 19:28 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 6,399 | $71.73 | $459,013.07 |
DisclosureSEC source: 0001246360-17-002910 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,014 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $71.73 - $ 71.76 Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 21:35 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 22,891 | $71.54 | $1,637,532.87 |
DisclosureSEC source: 0001246360-17-002878 · form.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,413 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F4 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $71.26 - $71.745 F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 21:35 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 98,509 | $70.54 | $6,948,992.33 |
DisclosureSEC source: 0001246360-17-002878 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,304 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $70.26 - $71.25 Read SEC document |
| September 19, 2017 Filed Sep 19, 2017 18:28 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 8,043 | $69.80 | $561,383.71 |
DisclosureSEC source: 0001246360-17-002772 · form.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,813 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F4 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $69.73 - $70.18 F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 18, 2017 Filed Sep 19, 2017 18:28 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 16,957 | $69.74 | $1,182,616.79 |
DisclosureSEC source: 0001246360-17-002772 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,856 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $69.73 - $69.95 Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 19:28 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 46,097 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002326 · form.xml · derivative · entry 3 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,197 Underlying: XLNX COMMON STOCK · 46,097 shares Expires 2019-07-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 19:28 UTC | XILINX INC XLNX · Entity 130374 | Tax withholdingXLNX COMMON STOCK | 24,054 | $64.71 | $1,556,534.34 |
DisclosureSEC source: 0001246360-17-002326 · form.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,813 Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 19:28 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 46,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002326 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 21:00 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 79,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002313 · form.xml · derivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,500 Underlying: XLNX COMMON STOCK · 79,500 shares Expires 2022-07-03 F1 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F3 · derivative.exercise_date: Subject to continued employment through each applicable vesting date, one-third of the units subject to the award will vest on each of July 3, 2020, July 3, 2021 and July 3, 2022, respectively. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 21:00 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 79,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002313 · form.xml · derivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,500 Underlying: XLNX COMMON STOCK · 79,500 shares Expires 2021-07-03 F1 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.exercise_date: Subject to continued employment through each applicable vesting date, one-third of the units subject to the award will vest on each of July 3, 2019, July 3, 2020 and July 3, 2021, respectively. Read SEC document |
| July 01, 2017 Filed Jul 3, 2017 16:00 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 27,739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002252 · form.xml · derivative · entry 5 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: XLNX COMMON STOCK · 27,739 shares Expires 2017-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 01, 2017 Filed Jul 3, 2017 16:00 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionRestricted Stock Unit · Derivative | 32,917 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002252 · form.xml · derivative · entry 4 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,917 Underlying: XLNX COMMON STOCK · 32,917 shares Expires 2018-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. F2 · derivative.expiration_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| July 01, 2017 Filed Jul 3, 2017 16:00 UTC | XILINX INC XLNX · Entity 130374 | Tax withholdingXLNX COMMON STOCK | 31,652 | $64.32 | $2,035,856.64 |
DisclosureSEC source: 0001246360-17-002252 · form.xml · nonDerivative · entry 3 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,770 Read SEC document |
| July 01, 2017 Filed Jul 3, 2017 16:00 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 27,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002252 · form.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| July 01, 2017 Filed Jul 3, 2017 16:00 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 32,917 | $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-002252 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This report reflects the settlement of previously issued restricted stock units. Each restricted stock unit represents a right to receive one share of Xilinx common stock. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 16:28 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 24,600 | $67.79 | $1,667,560.20 |
DisclosureSEC source: 0001246360-17-002143 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,766 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $67.7300 - $67.9100. Read SEC document |
| May 25, 2017 Filed May 26, 2017 11:07 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionNQSO (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $25.39 | $0.00 |
DisclosureSEC source: 0001246360-17-002019 · form.xml · derivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: XLNX COMMON STOCK · 26,000 shares Expires 2017-07-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2017 Filed May 26, 2017 11:07 UTC | XILINX INC XLNX · Entity 130374 | Exercise / conversionXLNX COMMON STOCK | 26,000 | $25.39 | $660,140.00 |
DisclosureSEC source: 0001246360-17-002019 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 23, 2017 18:21 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 400 | $67.73 | $27,092.00 |
DisclosureSEC source: 0001246360-17-002002 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,366 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: All Shares sold at same price. Read SEC document |
| May 15, 2017 Filed May 16, 2017 17:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 600 | $64.75 | $38,848.98 |
DisclosureSEC source: 0001246360-17-001883 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,766 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $64.7300 - $64.8300 F3 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 11, 2017 Filed May 12, 2017 16:14 UTC | XILINX INC XLNX · Entity 130374 | GrantRestricted Stock Unit · Derivative | 138,294 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001246360-17-001862 · form.xml · derivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,294 Underlying: XLNX COMMON STOCK · 138,294 shares Expires 2019-07-05 F1 · security: Each restricted stock unit represents a contingent right to receive one share of XLNX common stock upon vesting of the unit. F2 · derivative.exercise_date: Subject to the continued employment of the reporting person through the applicable vesting date, the restricted stock units will vest in three substantially equal installments and be settled on each of the first three anniversaries of the date of grant through the expiration date indicated. Date Exercisable refers to the initial grant vesting date. Read SEC document |
| May 10, 2017 Filed May 11, 2017 08:56 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 1,800 | $64.77 | $116,584.92 |
DisclosureSEC source: 0001246360-17-001804 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,366 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $64.73 - $64.92 Read SEC document |
| May 09, 2017 Filed May 9, 2017 19:07 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 6,900 | $64.87 | $447,610.59 |
DisclosureSEC source: 0001246360-17-001787 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 238,166 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $64.7300 - $65.1800 F3 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2017 Filed May 9, 2017 09:56 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 15,300 | $64.78 | $991,129.41 |
DisclosureSEC source: 0001246360-17-001781 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,066 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $64.73 - $64.94 F3 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 20:00 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 200 | $64.79 | $12,958.00 |
DisclosureSEC source: 0001246360-17-001648 · form.xml · nonDerivative · entry 3 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,366 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F5 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $64.7800 - $64.800. F3 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 20:00 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 21,900 | $64.17 | $1,405,410.60 |
DisclosureSEC source: 0001246360-17-001648 · form.xml · nonDerivative · entry 2 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,566 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F4 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $63.7700 - $64.7300 F3 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 27, 2017 Filed Apr 28, 2017 20:00 UTC | XILINX INC XLNX · Entity 130374 | SaleXLNX COMMON STOCK | 3,300 | $63.39 | $209,196.90 |
DisclosureSEC source: 0001246360-17-001648 · form.xml · nonDerivative · entry 1 GAVRIELOV MOSHE · CIK 0001165737 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,466 F1 · date: Acquisition/Disposition of Derivative and/or Non-Derivative securities is pursuant to a 10b5-1 Plan. F2 · shares: Price represents weighted average for sales reported. The range of prices for the sales reported is $62.7600 - $63.7500. F3 · shares: The reporting person will provide upon request by the commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.